Does the order of endurance and strength training in COPD rehab matter for muscle strength?
Official title: Effect of Intra-Session Training Order of Cardiorespiratory Endurance Work and Muscle Strengthening in COPD Patients
Run by CHU de Reims · NCT07655011 · Data updated 2026-11-12
This study tests whether doing strength training before endurance training during pulmonary rehab improves muscle strength in adults with COPD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Status | Recruiting |
| Started | August 6, 2026 |
| Main results expected | August 2028 |
| Study ends | January 2030 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07655011 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with COPD (GOLD stages 2–4) admitted for pulmonary rehabilitation who can read and speak French.
✕Probably not a fit
Patients unable to participate in one of the training modalities or with contraindications to exercise may receive less or no additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the effect of exercise order within a pulmonary rehabilitation session for adults with COPD. Participants will be assigned to either beginning with muscle strengthening or starting with endurance training in their rehab sessions. The trial focuses on practical exercise sequencing to see if the order influences muscle strength outcomes. It uses standard pulmonary rehab components and targets clinically relevant muscle function as a key endpoint. The setting is a COPD rehabilitation center in Reims, France, led by CHU de Reims.
Why it matters
Potential benefit: If successful, patients with COPD may experience greater gains in muscle strength from their rehabilitation sessions.
How similar studies have gone: Previous studies in healthy populations suggest the order of endurance and strength training can affect gains, but this COPD-specific approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * COPD GOLD stages 2 to 4 * Admitted for pulmonary rehabilitation in a participating center * Ability to read and speak French * Written informed consent * Affiliation with a social security system Exclusion Criteria: * Legal protection (guardianship or trusteeship) * Pregnancy beyond the second trimester * Musculoskeletal disorders affecting lower limb strength or walking performance * Vascular disease limiting walking distance * Cardiac contraindication to pulmonary rehabilitation
Where it's running
-
Chu Reims
Reims, France Recruiting
Study contacts
- Study coordinator: Amandine RAPIN
- Email: arapin@chu-reims.fr
- Phone: 03 26 78 42 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation
This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.